Companies / Health Care
MTD
Mettler Toledo
Life Sciences Tools & Services
Life Sciences Tools & ServicesAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health69
Growth33
Profitability86
Cash generation82
Balance sheet41
Dilution control100
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)6.3%Revenue growth (FY)4.0%Revenue CAGR (3y)0.9%Gross margin59.4%Operating margin—Net margin21.6%Free cash flow margin21.1%R&D / revenue5.0%Stock comp / revenue0.6%Net debt / operating cash flow2.18xCurrent ratio1.14Diluted share count change-3.0%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $3.7B | $3.9B | $3.8B | $3.9B | $4.0B |
| Gross profit | $2.2B | $2.3B | $2.2B | $2.3B | $2.4B |
| Net income | $769M | $873M | $789M | $863M | $869M |
| Operating cash flow | $909M | $859M | $966M | $968M | $956M |
| Capital expenditure | $108M | $121M | $105M | $104M | $107M |
| Free cash flow | $801M | $738M | $861M | $864M | $849M |
| R&D | $170M | $177M | $185M | $189M | $199M |
| Stock-based comp | $20M | $20M | $18M | $20M | $23M |
| Buybacks | $1000M | $1.1B | $900M | $850M | $800M |
| Cash | $99M | $96M | $70M | $59M | $67M |
| Total debt | $1.7B | $2.0B | $2.1B | $2.0B | $2.2B |
| Equity | $171M | $25M | -$150M | -$127M | -$24M |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.